The UK prepares for cannabis reform after a landmark week in the news, and a number of high-profile medical cannabis cases. Meanwhile, Malta issues its first import licence to Aphira subsidiary, ASG Pharma, and Speakeasy Cannabis Clubs look to expand into the German market.
Parisians line up to buy low-THC ‘cannabis light’ in newly opened store, while German insurers release their first insights into the business of covering medical cannabis. Elswhere, UK border force confiscates ‘openly smuggled’ cannabis oil from Charlotte Caldwell, as she attempts to treat her severely epileptic son.
A new study finds that legalising cannabis could boost UK tax revenue by up to £3.5 billion per year, while the global drinks industry, suggests cannabis is its single biggest threat. Meanwhile, after weeks of raids, Denmark’s Freetown Christiania market finally concedes and stops selling cannabis. Also in the news is an early test suggesting that cannabis could effectively treat symptoms of Lyme disease.
GW Pharma makes a breakthrough with US Food and Drug Administration, while Aurora heavily expands it’s German market presence. Meanwhile, a new study finds that the majority of Britons would prefer a softer stance on cannabis, as the French Health Minister suggests medical cannabis could be on its way…
Maricaan Group closes the acquisition of Swiss company Haxxon, as Organigram sets up to acquire 25% of German company Alpha-Cannabis. Marches in Peru and Argentina demand new cannabis laws, while the British Medical Journal argues for legalised, regulated and taxed cannabis. Meanwhile, new studies suggest cannabis could treat anxiety, depression and PTSD.
German police associations calls for decriminalisation as Portuguese health experts weigh in on the cannabis debate. Meanwhile Greece is fast tracking cannabis legislation in a bid to boost economy. Our customary country review investigates the new cannabis legislation in Turkey and how they aim to combat international narco-trafficking.